United States · FDA National Drug Code directory
Lurasidone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 23155-890_5e2349ce-8e0d-4347-b74e-f5ae23763f29
- Product NDC
- 23155-890
- Form
- TABLET, FILM COATED
- Composition / generic term
- Lurasidone Hydrochloride
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231019
- Source listing expiry
- 20271231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (23155-890-03) · 23155-890-03
- 500 TABLET, FILM COATED in 1 BOTTLE (23155-890-05) · 23155-890-05
- 90 TABLET, FILM COATED in 1 BOTTLE (23155-890-09) · 23155-890-09
- 30000 TABLET, FILM COATED in 1 CONTAINER (23155-890-18) · 23155-890-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →